COMPASS Pathways plc Share Price & Technical Analysis
CMPS · $11.81 (+1.90%)
Healthcare / Medical Care Facilities
$11.81
+1.90%
COMPASS Pathways plc operates as a biotechnology company that focuses on mental health in the United Kingdom and the United States. The company develops COMP360, a psilocybin therapy, which is in Phase III clinical trial for the treatment of treatment-resistant depression; and is in Phase II clinical trial for treating post-traumatic stress disorder and anorexia nervosa. The company was formerly k…
Price chart
Seasonality
May has 2 positive and 3 negative years (last 5 years shown)
30% return in May, -6% avg return in past 3 year May month.
73% return in 2026, 24% avg return in past 3 years.
Swipe sideways to see all months →
| Jan | Feb | Mar | Apr | May | Jun | Jul | Aug | Sep | Oct | Nov | Dec | Yr | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 26 | -4% | 3% | -18% | 63% | 30% | – | – | – | – | – | – | – | 73% |
| 25 | 13% | -5% | -27% | 43% | 5% | -33% | 54% | 2% | 30% | 11% | -11% | 25% | 106% |
| 24 | 30% | -8% | -19% | -2% | -13% | -19% | 27% | -3% | -17% | -24% | -4% | -17% | -69% |
| 23 | 28% | -22% | 19% | -20% | -9% | 14% | 13% | -1% | -19% | -23% | 5% | 49% | 36% |
| 22 | -29% | -11% | -10% | -28% | -1% | 16% | 43% | 3% | -36% | -5% | -8% | -23% | -89% |
Monthly return % by calendar month · historical pattern, not a forecast
Neutral · Strong · Strong
COMPASS Pathways plc operates as a biotechnology company that focuses on mental health in the United Kingdom and the United States. The company develops COMP360, a psilocybin therapy, which is in Phase III clinical trial for the treatment of treatment-resistant depression; and is in Phase II clinical trial for treating post-traumatic stress disorder and anorexia nervosa. The company was formerly known as COMPASS Rx Limited and changed its name to COMPASS Pathways plc in August 2020. The company was incorporated in 2020 and is headquartered in London, the United Kingdom.
Full AI Q&A, portfolio tracking, and live alerts in the app.
Key metrics
Market cap
$1.25B
P/E ratio
—
52W high
$12.23
52W low
$2.25
Volume
38,71,017
Beta
2.40
Related stocks in Healthcare
Merck & Co Inc Cedear (5…
₹32,900
Abbott Laboratories Cede…
₹30,500
Eli Lilly And Company Ce…
₹25,540
Unitedhealth Group Inc C…
₹17,200
₹6,600
Frequently asked questions
- What is COMPASS Pathways plc share price today?
- COMPASS Pathways plc (CMPS) last traded around $11.81 on StockPro. Prices refresh every few minutes during market hours.
- What technical signals does CMPS have?
- StockPro monitors breakouts, volume spikes, EMA reversals, and momentum for CMPS. Download the app for real-time alerts.
- How can I analyze COMPASS Pathways plc stock?
- Use the price chart, seasonality heatmap, key metrics, and AI insight on this page. For portfolio tracking and push alerts, download StockPro on Android or iOS.